Which stock rocked the table with a double downgrade? The Investment Committee reveals today's Calls of the Day!

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

Fintel reports that on April 28, 2025, HSBC downgraded their outlook for Eli Lilly and (NYSE:LLY) from Buy to Reduce. Analyst ...

With its 2-star rating, we believe Lilly stock is overvalued compared with our long-term fair value estimate of $650 per ...

In an exclusive to ADWEEK, ESPN announced Eli Lilly and Company as the presenting sponsor of the summit, which first launched ...

HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.

Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $12.62 billion and $3.52 per share, ...

Eli Lilly And Co (NYSE:LLY) stock is 1.6% lower to trade at $870.31 at last check, after a rare double downgrade from HSBC to "reduce" from "buy," and a price-target cut to $700 from $1,150. The ...

As the tariff wars continue to unfold, the markets are attempting to kick off the week with gains as the latest slew of tech ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.

IBM is making a major bet on America's tech future. The company announced plans on Monday to invest $150 billion across the ...